5975 — Topre Balance Sheet
0.000.00%
- ¥114bn
- ¥106bn
- ¥374bn
- 74
- 95
- 90
- 99
Annual balance sheet for Topre, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 39,328 | 50,104 | 49,923 | 56,629 | 71,055 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 52,285 | 47,257 | 59,830 | 66,848 | 60,016 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 130,162 | 133,419 | 147,598 | 168,498 | 173,927 |
| Net Property, Plant And Equipment | 154,229 | 159,256 | 159,085 | 163,237 | 164,935 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 309,790 | 320,013 | 339,376 | 365,525 | 371,086 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 81,525 | 87,618 | 100,318 | 118,438 | 108,414 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 147,647 | 143,268 | 148,279 | 152,281 | 151,435 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 162,143 | 176,745 | 191,097 | 213,244 | 219,651 |
| Total Liabilities & Shareholders' Equity | 309,790 | 320,013 | 339,376 | 365,525 | 371,086 |
| Total Common Shares Outstanding |